Joe Biegel
Director
 
Mr. Biegel is the Vice President of Product Management and Marketing for the Medical Imaging Division of McKesson Provider Technologies. He joined McKesson in 2004 and is responsible for developing product strategy and plans for the growing family of diagnostic imaging IT solutions from the McKesson Imaging Group.

Mr. Biegel has been working in digital imaging for over 27 years, and in diagnostic imaging for 19 years. Prior to joining McKesson, he served as Vice President of Business Development for Agfa Healthcare.  Before joining Agfa, he had senior roles in diagnostic imaging product development and marketing at Hewlett-Packard’s Medical Products Group, Polaroid Medical Imaging Systems and the DuPont Merck Pharmaceutical Company.  Mr. Biegel also was on the faculty of the Rochester Institute of Technology's Center for Imaging Science where he taught courses in imaging and computing and was involved in contract research programs for NASA and other US Government organizations.

Karen Boodram, B.Sc., MBA
Director

Karen Boodram comes to us from PI Financial Corp. where she served as a Life Sciences Analyst and has over 18 years of life sciences industry experience including Director of External Affairs for Novartis Pharmaceuticals and several senior management positions (including Manager of Health Economics) for Ciba-Geigy Pharmaceuticals, spanning both the Canadian and European marketplace. Prior to joining PI Financial Corp., Karen led BioManna Consulting where she spearheaded and managed projects for the National Research Council as well as biotechnology, pharmaceutical and medical device companies in North America. Karen is a graduate of the University of Alberta with Bachelor of Science Degrees in Biochemistry and Pharmacy as well as an MBA. She is also a member of the Alberta Pharmaceutical Association.

Thomas Braun BA, JD, LLM
Director      

Prior to founding the company, Thomas Braun practiced corporate securities law at Braun and Co., specializing in representing small high tech public companies. Mr. Braun is experienced in the management of public companies and has conducted dozens of mergers and acquisitions and going public transactions.

Mr. Braun earned a BA degree from the University of Western Ontario, a Juris Doctor (JD) degree from the University of British Columbia, and a Master of Laws (LLM) degree from the University of San Francisco specializing in International Business Transactions. He is a member of the State Bar of California, and the American Bar Association; and is also a member of the Law Society of British Columbia and the Canadian Bar Association. He is also admitted to practice before the Federal Court for the Northern District of California and the Ninth Circuit Court Appeals.

Chris Dennis, MBA
Director

Chris Dennis was formerly Senior Vice President Global Commercial Operations for Angiotech Pharmaceuticals and Global President OrthoNeutrogena: Pharma and Medical Devices (a Johnson & Johnson company).  Chris was with J&J for a total of 18 years in senior marketing executive roles.  He has managed large sales and marketing departments and generated millions of dollars in sales for the various organizations that he has managed.  Chris holds an MBA from Athabasca University.

Dr. Jake Thiessen, Ph.D.
Director

Dr. Jake J. Thiessen is the Hallman Director, School of Pharmacy, and Director, Health Sciences Campus, University of Waterloo.  Jake is a former professor and associate dean at the Leslie Dan Faculty of Pharmacy, University of Toronto. He earned his B.Sc. (Pharm) degree from the University of Manitoba, and went on to complete a M.Sc. at Manitoba and a Ph.D. at the University of California, San Francisco. Jake’s area of specialization is pharmacokinetics. His research interests include new approaches in cancer treatment and new molecules to treat patients with iron overload. He has broadened his experience and shared his expertise through work with the Drug Quality and Therapeutics Committee of the Ontario Ministry of Health, Health Canada’s Scientific Advisory Committee on Bioavailability and Bioequivalence, and the Canadian Council for Accreditation of Pharmacy Programs. As Director, Jake has overall strategic responsibility for establishing UW’s  new School of Pharmacy and implementing a full educational program.